RecruitingMyelodysplastic Syndromes, Adult
Defining Inflammatory Markers of Cardiovascular Disease in Patients With Myelodysplastic Syndromes
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Why Is This Research Study Being Conducted? * The study wants to find out why people with a type of blood cancer called myelodysplastic syndromes (MDS) are more likely to have heart problems like heart disease and stroke. * Researchers also want to see if certain proteins related to inflammation in the body can help predict these heart issues in MDS patients. * By understanding this better, researchers hope to find new ways to detect and manage heart disease risks in people with MDS
Sponsor: University of Vermont
You may qualify if…
- ✓ Age ≥18 years
- ✓ Histologically confirmed diagnosis of MDS by bone marrow biopsy morphology, using the 2022 World Health Organization (WHO) classification for myeloid neoplasms
- ✓ Eastern Cooperative Oncology Group (ECOG) performance status ≤3
- ✓ Expected survival of at least 6 months
- ✓ Ability to provide consent
You may not qualify if…
- ✕ Cases meeting 2022 WHO criteria of MDS with excess blasts 2 as initial diagnosis
- ✕ Hematopoietic stem cell transplantation expected within 6 months
Where it's recruiting
Vermont
Burlington
Source: ClinicalTrials.gov · NCT06692894 · last updated 2026-02-03